{
  "trial_id": "NCT00393029",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, clinical performance status (ECOG), life expectancy, HIV status, hepatitis B status, hepatitis C status, HLA-A 0201 status, absolute neutrophil count, white blood cell count, platelet count, hemoglobin level, serum ALT/AST levels, serum creatinine level, total bilirubin level, prior systemic therapy history, pregnancy status, biopsy evaluability for p53 expression.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "clinical performance status (ECOG)",
        "life expectancy",
        "HIV status",
        "hepatitis B status",
        "hepatitis C status",
        "HLA-A 0201 status",
        "absolute neutrophil count",
        "white blood cell count",
        "platelet count",
        "hemoglobin level",
        "serum ALT/AST levels",
        "serum creatinine level",
        "total bilirubin level",
        "prior systemic therapy history",
        "pregnancy status",
        "biopsy evaluability for p53 expression."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Cancer Type, Previous Treatments, ECOG Performance Status, Life Expectancy, HIV Status, Hepatitis B Status, Hepatitis C Status, HLA-A 0201 Status, Absolute Neutrophil Count, White Blood Cell Count, Platelet Count, Hemoglobin Level, Serum ALT/AST Levels, Serum Creatinine Level, Total Bilirubin Level, Time Since Last Systemic Therapy, Pregnancy Test (for women of child-bearing potential),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Cancer Type",
        "Previous Treatments",
        "ECOG Performance Status",
        "Life Expectancy",
        "HIV Status",
        "Hepatitis B Status",
        "Hepatitis C Status",
        "HLA-A 0201 Status",
        "Absolute Neutrophil Count",
        "White Blood Cell Count",
        "Platelet Count",
        "Hemoglobin Level",
        "Serum ALT/AST Levels",
        "Serum Creatinine Level",
        "Total Bilirubin Level",
        "Time Since Last Systemic Therapy",
        "Pregnancy Test (for women of child-bearing potential)"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Life Expectancy, HIV Status, Hepatitis B and C Status, HLA-A 0201 Status, Absolute Neutrophil Count, White Blood Cell Count, Platelet Count, Hemoglobin, Serum Alanine Aminotransferase, Serum Aspartate Aminotransferase, Serum Creatinine, Total Bilirubin.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "ECOG Performance Status",
        "Life Expectancy",
        "HIV Status",
        "Hepatitis B and C Status",
        "HLA-A 0201 Status",
        "Absolute Neutrophil Count",
        "White Blood Cell Count",
        "Platelet Count",
        "Hemoglobin",
        "Serum Alanine Aminotransferase",
        "Serum Aspartate Aminotransferase",
        "Serum Creatinine",
        "Total Bilirubin"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, life expectancy, HIV status, hepatitis B and C status, HLA-A 0201 status, cancer type, metastatic disease status, prior systemic therapy, prior IL-2 therapy, absolute neutrophil count, white blood cell count, platelet count, hemoglobin, serum ALT/AST, serum creatinine, total bilirubin, clinical tumor regression at baseline.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "life expectancy",
        "HIV status",
        "hepatitis B and C status",
        "HLA-A 0201 status",
        "cancer type",
        "metastatic disease status",
        "prior systemic therapy",
        "prior IL-2 therapy",
        "absolute neutrophil count",
        "white blood cell count",
        "platelet count",
        "hemoglobin",
        "serum ALT/AST",
        "serum creatinine",
        "total bilirubin",
        "clinical tumor regression at baseline."
      ]
    }
  }
}